Marcello Holanda de Andrade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marcello Holanda de Andrade has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Alissa Elen Formiga Moura
Universidade Federal do Ceará, Hospital Universitário Walter Cantídio, Departamento de Neurologia, Fortaleza CE, Brazil
1 shared publication - Ana Karoline da Costa Monteiro
Universidade Federal do Piauí
1 shared publication - Antônio Alves Sobreira-Neto
Universidade Federal do Ceará, Brazil
1 shared publication - Chiara Gübel Portugal
Universidade Federal do Ceará, Brazil
1 shared publication - Danielle Barcellos Morais
Centro de Atenção Psicossocial para Álcool e Drogas
1 shared publication - Emanuel de Assis Bertulino Martins Gomes
Universidade Federal do Ceará, Brazil
1 shared publication
Latest Publications
- Open Access
- 2 September 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (9)
Perfil clínico e epidemiológico de pacientes com migrânea tratados na clínica de neurologia de um hospital universitário
O presente estudo buscou avaliar o perfil clínico e epidemiológico dos pacientes com migrânea atendidos no ambulatório de neurologia de um Hospital Universitário. Tratou-se de um estudo quantitativo, descritivo, observacional e retrospectivo com pacientes adultos diagnosticados com migrânea, atendidos de 1º de janeiro a 31 de dezembro de 2021. Informações sociodemográficas e clínicas foram coletadas dos prontuários. Foram incluídos 247 pacientes, predominantemente mulheres (93,5%), com idade média de 43,7 anos, casados (48,6%), sem histórico familiar (56,0%) ou tratamento prévio (57,7%). Cerca de 74,9% relataram comorbidades, sendo HAS (26,2%) e transtornos psiquiátricos (12,6%) os mais prevalentes. Houve associação significativa entre a quantidade de dias de migrânea por mês e a presença de comorbidades (p< 0,05) e entre migrânea crônica e comorbidades (OR 2,65). Esta pesquisa caracterizou o perfil clínico e epidemiológico dos pacientes, confirmando que comorbidades estão associadas à cronificação da migrânea e interferem nas atividades cotidianas.
- 2 September 2024
- Published by Research, Society and Development in Research, Society and Development
- Vol. 13 (9)
Open AccessPerfil clínico e epidemiológico de pacientes com migrânea tratados na clínica de neurologia de um hospital universitário
O presente estudo buscou avaliar o perfil clínico e epidemiológico dos pacientes com migrânea atendidos no ambulatório de neurologia de um Hospital Universitário. Tratou-se de um estudo quantitativo, descritivo, observacional e retrospectivo com pacientes adultos diagnosticados com migrânea, atendidos de 1º de janeiro a 31 de dezembro de 2021. Informações sociodemográficas e clínicas foram coletadas dos prontuários. Foram incluídos 247 pacientes, predominantemente mulheres (93,5%), com idade média de 43,7 anos, casados (48,6%), sem histórico familiar (56,0%) ou tratamento prévio (57,7%). Cerca de 74,9% relataram comorbidades, sendo HAS (26,2%) e transtornos psiquiátricos (12,6%) os mais prevalentes. Houve associação significativa entre a quantidade de dias de migrânea por mês e a presença de comorbidades (p< 0,05) e entre migrânea crônica e comorbidades (OR 2,65). Esta pesquisa caracterizou o perfil clínico e epidemiológico dos pacientes, confirmando que comorbidades estão associadas à cronificação da migrânea e interferem nas atividades cotidianas.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 18, e20230076
Long COVID: neurological manifestations - an updated narrative review
Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 18, e20230076
Open AccessLong COVID: neurological manifestations - an updated narrative review
Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.
- Open Access
- 1 January 2021
- Published by Zeppelini Editorial e Comunicacao
- p. 35
Fahr’s Syndrome: A Case Report
Context: Fahr’s syndrome is a clinical entity of primary or secondary causes characterized by neurological and/or psychiatric symptoms associated with abnormal calcifications in basal ganglia, cerebellum and cerebral cortex. Case report: G.M.A, female, 49 years-old, presented athetosis in the distal extremity of the right upper limb (RUL) in December 2020, without seeking for medical help. Known to be diabetic, hypertensive and with diastolic heart failure (HF), in February 2021 she presented decompensated HF associated with worsening of involuntary movements in the RUL. During investigation, abnormalities in serum levels of parathormone (PTH) and calcium were observed, in addition to bilateral calcifications in basal ganglia and thalamus in brain computed tomography (CT) without contrast. In March 2021, she was admitted to the University Hospital of the Federal University of Piauí, with maintenance of athetosis at the distal extremity of the RUL, in addition to oromandibular dyskinesia. Laboratory profile compatible with primary hypoparathyroidism and new brain CT without contrast with calcifications in basal ganglia and pulvinar of the thalamus, bilaterally, were confirmed. Intravenous calcium replacement and use of calcitriol were performed, with partial clinical improvement. Conclusions: Fahr’s syndrome is characterized by the presence of movement disorders (with highlights for parkinsonism and athetosis) and psychiatric symptoms (depression most commonly). Possible etiologies are primary (genetic) and secondary (mainly idiopathic or secondary hypoparathyroidism). Classic finding of symmetrical calcifications in base nuclei is seen on brain CT. Treatment is symptomatic and control of the underlying disease.
- 1 January 2021
- Published by Zeppelini Editorial e Comunicacao
- p. 35
Open AccessFahr’s Syndrome: A Case Report
Context: Fahr’s syndrome is a clinical entity of primary or secondary causes characterized by neurological and/or psychiatric symptoms associated with abnormal calcifications in basal ganglia, cerebellum and cerebral cortex. Case report: G.M.A, female, 49 years-old, presented athetosis in the distal extremity of the right upper limb (RUL) in December 2020, without seeking for medical help. Known to be diabetic, hypertensive and with diastolic heart failure (HF), in February 2021 she presented decompensated HF associated with worsening of involuntary movements in the RUL. During investigation, abnormalities in serum levels of parathormone (PTH) and calcium were observed, in addition to bilateral calcifications in basal ganglia and thalamus in brain computed tomography (CT) without contrast. In March 2021, she was admitted to the University Hospital of the Federal University of Piauí, with maintenance of athetosis at the distal extremity of the RUL, in addition to oromandibular dyskinesia. Laboratory profile compatible with primary hypoparathyroidism and new brain CT without contrast with calcifications in basal ganglia and pulvinar of the thalamus, bilaterally, were confirmed. Intravenous calcium replacement and use of calcitriol were performed, with partial clinical improvement. Conclusions: Fahr’s syndrome is characterized by the presence of movement disorders (with highlights for parkinsonism and athetosis) and psychiatric symptoms (depression most commonly). Possible etiologies are primary (genetic) and secondary (mainly idiopathic or secondary hypoparathyroidism). Classic finding of symmetrical calcifications in base nuclei is seen on brain CT. Treatment is symptomatic and control of the underlying disease.